Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1a/b Trial of Exercise as Interception Therapy for Primary High-Risk Cancer

NCT04589468 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT04589468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04589468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1a/b Trial of Exercise as Interception Therapy for Primary High-Risk Cancer
Lead sponsor
City of Hope Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
October 30, 2026
Completion date
February 13, 2028
Enrollment
51 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colorectal cancer, prostate cancer, stage i breast cancer, stage i colorectal cancer, stage i prostate cancer, stage ii breast cancer, stage ii colorectal cancer, stage ii prostate cancer, stage iii breast cancer, stage iii colorectal cancer, stage iii prostate cancer